Mitochondria driven innate immune signaling and inflammation in cancer growth, immune evasion, and therapeutic resistance
Authors:
- 13 March 2024
- book chapter
- Published by Elsevier
- Vol. 386, 223-247
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Re-awakening Innate Immune Signaling in Cancer: The Development of Highly Potent ENPP1 InhibitorsCell Chemical Biology, 2020
- Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4Cellular and Molecular Life Sciences, 2019
- Myc Cooperates with Ras by Programming Inflammation and Immune SuppressionCell, 2017
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint BlockadeCell, 2016
- Activation of apoptosis signalling pathways by reactive oxygen speciesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its TreatmentCell, 2016
- Role of interleukin-6 in cancer progression and therapeutic resistanceTumor Biology, 2016
- Interactions between mitochondrial reactive oxygen species and cellular glucose metabolismArchives of Toxicology, 2015
- New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escapeCurrent Opinion in Immunology, 2014
- Reactive oxygen species-dependent signaling regulates cancerCellular and Molecular Life Sciences, 2009